The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Urgent balloon aortic valvuloplasty in cardiogenic shock patients: still state of the art in the TAVI era?

EuroIntervention 2018;14:e494-e495 published online e-edition August 2018. DOI: 10.4244/EIJV14I5A87

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany


For a decade, percutaneous balloon aortic valvuloplasty (BAV) was a treatment option for high surgical risk and inoperable patients with severe aortic stenosis (AS). It was first described by Cribier et al in 19861. Six years later, in 1992, Cribier et al reported the results of 10 patients treated by BAV as a life-saving procedure in an emergency setting due to cardiogenic shock (CS)2. In 2012, BAV was regarded as a bridge to surgery or transcatheter aortic valve implantation (TAVI) in haemodynamically unstable patients at high surgical risk, and as a palliative treatment alternative in patients for whom neither surgery nor TAVI was ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Reducing radiation exposure during PCI of chronic total occlusions – better is not good enough